SOLUTION
The human immune system is undoubtedly a complex environment of interconnected systems. Understanding how these systems pathways work and how they can be influenced to mitigate disease and suffering is a rapidly growing field of study. Therapies in this area cross categories of medicine from inflammatory disorders, autoimmune disease to neurodegenerative, some rare diseases and even cancer.
At Jameel Health, we’re partnering with innovators looking to exploit these metabolic pathways to develop a whole new platform of convenient, and importantly affordable treatments for a wide range of ailments.
الشريك المميز
Evelo Biosciences (NASDAQ: EVLO) is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on SINTAX™, the small intestinal axis, with systemic therapeutic effects. Cells in the small intestine are known to play a central role in governing the body’s immune, metabolic and neurological systems.
Visit
انظر جميع الشركاء
شركاء آخرين
